G
Gerald Yong
Researcher at Fiona Stanley Hospital
Publications - 44
Citations - 1550
Gerald Yong is an academic researcher from Fiona Stanley Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 17, co-authored 37 publications receiving 1310 citations. Previous affiliations of Gerald Yong include Sir Charles Gairdner Hospital & Royal Perth Hospital.
Papers
More filters
Journal ArticleDOI
Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects.
Jennifer H. Walsh,Gerald Yong,Craig Cheetham,Gerald F. Watts,Gerard O'Driscoll,Roger R. Taylor,Daniel J. Green +6 more
TL;DR: Combined aerobic and resistance training improves endothelium-dependent conduit and resistance vessel function in hypercholesterolaemic subjects taking lipid-lowering medications and basal nitric oxide bioactivity in untreated hyperCholesterolaemia subjects.
Journal ArticleDOI
Prevalence, Factors Associated With, and Prognostic Effects of Preoperative Anemia on Short- and Long-Term Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation
Rutger-Jan Nuis,Jan-Malte Sinning,Josep Rodés-Cabau,Michael Gotzmann,Leen van Garsse,Joelle Kefer,Johan Bosmans,Gerald Yong,Antonio Dager,Ana Revilla-Orodea,Marina Urena,Georg Nickenig,Nikos Werner,Jos G. Maessen,Parla Astarci,Sergio Perez,Luis M. Benitez,Ignacio J. Amat-Santos,Javier E. López,Eric Dumont,Nicolas M. Van Mieghem,Teun van Gelder,Ron T. van Domburg,Peter de Jaegere +23 more
TL;DR: Findings indicate that optimization of baseline factors related to preoperative anemia, in addition to more strict criteria of the use of blood products, may improve outcome after TAVI.
Journal ArticleDOI
Predictive and Protective Factors Associated With Upper Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Case-Control Study
TL;DR: UGI bleeding in the 30 days following PCI for stable angina and acute coronary syndromes, at one institution between 1998 and 2005 is relatively common and associated with increased mortality.
Journal ArticleDOI
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
Raj Makkar,Wen Cheng,Ron Waksman,Lowell F. Satler,Tarun Chakravarty,Mark Groh,William Abernethy,Mark J. Russo,Mark J. Russo,David Heimansohn,James B. Hermiller,Stephen G. Worthley,Bassem M. Chehab,Mark J. Cunningham,Ray V. Matthews,Ravi K. Ramana,Gerald Yong,Carlos E. Ruiz,Chunguang Chen,Federico M. Asch,Mamoo Nakamura,Hasan Jilaihawi,Rahul Sharma,Sung Han Yoon,Augusto D. Pichard,Samir R. Kapadia,Michael J. Reardon,Deepak L. Bhatt,Gregory P. Fontana +28 more
TL;DR: A prospective, multicentre, non-inferiority, randomised controlled trial of the self-expanding intra-annular Portico transcatheter aortic valve system compared with any commercially available valves on the basis of safety and efficacy up to 2 years after the procedure.
Journal ArticleDOI
Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation
TL;DR: This work explored the predictive factors and prognostic implications of AKI following TAVI, and found that transcatheter aortic valve implantation poses a significant risk of acute kidney injury.